Patients with high-risk differentiated thyroid cancer have a lower I-131 ablation success rate than low-risk ones in spite of a high ablation activity-Reference-Cited by-同舟云学术

Patients with high-risk differentiated thyroid cancer have a lower I-131 ablation success rate than low-risk ones in spite of a high ablation activity

Published:2016-06-29 Issue:6 Volume:85 Page:926-931
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Winter J.¹,Winter M.¹,Krohn T.¹,Heinzel A.¹,Behrendt F.F.¹,Tuttle R.M.²,Mottaghy F.M.¹³,Verburg F.A.¹³

Affiliation:

1. Department of Nuclear Medicine; Aachen; RWTH University Hospital Aachen; Aachen Germany

2. Endocrinology Service; Memorial Sloan-Kettering Cancer Center; New York NY USA

3. Department of Nuclear Medicine; Maastricht UMC; Maastricht The Netherlands

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.13123/fullpdf

Reference27 articles.

1. Ho , A.L. Keating , K. Skolnik , J. et al 2013 The ASTRA study: adjuvant selumetinib for differentiated thyroid cancer (DTC); remission after radioiodine

2. Recombinant human thyrotropin in thyroid remnant ablation with 131-iodine in high-risk patients;Rosario;Thyroid,2010

3. High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal;Bartenstein;Thyroid,2014

4. The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma;Thies;European Journal of Nuclear Medicine and Molecular Imaging,2014

5. Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients;Verburg;European Journal of Endocrinology,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of integrin αvβ3-targeted imaging for predicting disease progression in patients with high-risk differentiated thyroid cancer (using 99mTc-3PRGD2);Cancer Imaging;2022-12-19

2. Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer;International Journal of Cancer;2020-05-09

3. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study;Updates in Surgery;2020-04-27

4. mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas;Yonsei Medical Journal;2018

5. Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management;Clinical Oncology;2017-05